Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

18.17
BATS BZX Real-Time Price
As of 11:11am ET
 +0.67 / +3.83%
Today’s Change
6.01
Today|||52-Week Range
19.12
+10.05%
Year-to-Date
5 Stocks Insiders Love Right Now
Jan 11 / TheStreet.com - Paid Partner Content
Can The Uptrend Continue for Aquinox Pharmaceuticals (AQXP)?
Jan 10 / Zacks.com - Paid Partner Content
Zynerba Pharmaceuticals (ZYNE) Jumps: Stock Rises 9.5%
Jan 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close17.50
Today’s open17.73
Day’s range17.73 - 18.18
Volume6,098
Average volume (3 months)243,865
Market cap$409.9M
Dividend yield--
Data as of 11:11am ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+37.09%
Earnings growth (this year)-15.26%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.06-0.61%
CTMXCytomX Therapeutics ...-0.06-0.53%
AVDLAvadel Pharmaceutica...+0.06+0.62%
MACKMerrimack Pharmaceut...-0.02-0.82%
Data as of 11:11am ET, 01/18/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$21.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Financial Officer, Secretary &
VP
Kamran Alam
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs